Top 15 Accounts to Follow on Twitter for Stem Cell News
In a July 2013 USA Today article, Rem Rieder discusses how Twitter “can function as a conveyor belt for first-rate journalism, bringing to your attention terrific material that you might otherwise never encounter”. He then goes on to point out that Twitter is a news pipeline for more than 200 million active users, often ‘breaking’ news before it’s actually news.
Especially for news pertaining to stem cells, Twitter is an indispensable resource.
Now, more and more people are looking to social media first for their news, rather than traditional news sites. Subscribing to stem cell news via Twitter will ensure you stay up to date with the stem cell world and the groundbreaking news that is constantly produced.
Below are our 15 favorite stem cell accounts to follow on Twitter. This is based on both qualitative and quantitative criteria that include:
- Frequency and quality of stem cell Tweets
- Scientific importance and relevance of Tweets
- Degree to which the Twitter feed focuses on the stem cell niche
- Valuable contributions to stem cell discussions on Twitter
- Who we actively follow and enjoy as a source of stem cell news
- Most importantly, whether the Tweets are informational, instead of including opinion, hype, or venting (this dropped a few accounts from the list)
My Favorite Accounts to Follow on Twitter for Stem Cell News
Of course, BioInformant also works incredibly hard at being resource for outstanding stem cells news, and we are now the fastest growing stem cell account on Twitter. Follow us on Twitter at BioInformant (@StemCellMarket) to get alerted to stem cell industry news, before your competition.
What Stem Cell Accounts would You Add or Remove?
Is there anyone that you would you like to see added to this list? Or removed? Make your suggestions in the comments below!
Want to be better informed than your competition? Get future stem cell industry updates.
BioInformant is the only research firm that has served the stem cell sector since it emerged. Our management team comes from a BioInformatics background – the science of collecting and analyzing complex genetic codes – and applies these techniques to the field of market research. BioInformant research has been cited by major news outlets that include the Wall Street Journal, Nature Biotechnology, CBS News, Medical Ethics, and the Center for BioNetworking. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, Goldman Sachs, and Becton Dickinson, BioInformant is your global leader in stem cell industry data.
Click here to view our global strategic reports for the stem cell and cord blood industry.